Structural basis for synthesis of inflammatory mediators by human leukotriene C4 synthase

Nature

Volumn 448, Issue 7153, 2007, Pages 613-616

  Molina, Daniel Martinez ^a,b   Wetterholm, Anders ^a   Kohl, Andreas ^a   McCarthy, Andrew A ^c   Niegowski, Damian ^a,b   Ohlson, Eva ^a   Hammarberg, Tove ^a   Eshaghi, Said ^a   Haeggström, Jesper Z ^a   Nordlund, Pär ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE; LEUKOTRIENE C4 SYNTHASE; MONOMER;

ASTHMA; CARDIOVASCULAR SYSTEM; CATALYSIS; DETOXIFICATION; ENZYME ACTIVITY; FATTY ACID; IMMUNE RESPONSE; MEMBRANE; METHANE; PEPTIDE; PROTEIN; SUBSTRATE;

ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; ENZYME ACTIVITY; ENZYME BINDING; ENZYME STRUCTURE; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; HYDROPHOBICITY; LIPOPHILICITY; PRIORITY JOURNAL;

EID: 34547688876     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature06009     Document Type: Article

References (28)

1. Lam, B. K. & Austen, K. F. Leukotriene C-4 synthase: A pivotal enzyme in cellular biosynthesis of the cysteinyl leukotrienes. Prostaglandins Other Lipid Mediat. 68-69, 511-520 (2002).
2. Samuelsson, B. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 220, 568-575 (1983).
3. Funk, C. D. Prostaglandins and leukotrienes: Advances in eicosanoid biology. Science 294, 1871-1875 (2001).
4. Samuelsson, B., Dahlén, S.-E., Lindgren, J.-Å., Rouzer, C. A. & Serhan, C. N. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 237, 1171-1176 (1987).
5. Hanna, C. J., Bach, M. K., Pare, P. D. & Schellenberg, R. R. Slow-reacting substances (leukotrienes) contract human airway and pulmonary vascular smooth-muscle in vitro. Nature 290, 343-344 (1981).
6. Dahlén, S.-E., Hedqvist, P., Hammarström, S. & Samuelsson, B. Leukotrienes are potent constrictors of human bronchi. Nature 288, 484-486 (1980).
7. Dahlén, S.-E. et al. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: In vivo effects with relevance to the acute inflammatory response. Proc. Natl Acad. Sci. USA 78, 3887-3891 (1981).
8. Weiss, J. W. et al. Bronchoconstrictor effects of leukotriene-C in humans. Science 216, 196-198 (1982).
9. Drazen, J. F., Israel, E. & O'Byrne, P. Treatment of asthma with drugs modifying the leukotriene pathway. N. Engl. J. Med. 340, 197-206 (1999).
10. Bisgaard, H. Leukotriene modifiers in pediatric asthma management. Pediatrics 107, 381-390 (2001).
11. Jakobsson, P. J., Morgenstern, R., Mancini, J., Ford-Hutchinson, A. & Persson, B. Common structural features of MAPEG - a widespread superfamily of membrane associated proteins with highly divergent functions in eicosanoid and glutathione metabolism. Protein Sci. 8, 689-692 (1999).
12. Morgenstern, R., Svensson, R., Bernat, B. A. & Armstrong, R. N. Kinetic analysis of the slow ionization of glutathione by microsomal glutathione transferase MGST1. Biochemistry (Mosc.) 40, 3378-3384 (2001).
13. Corey, E. J. et al. Stereospecific total synthesis of a "slow reacting substance" of anaphylaxis, leukotriene C4. J. Am. Chem. Soc. 102, 1436-1439 (1980).
14. Holm, P. J. et al. Structural basis for detoxification and oxidative stress protection in membranes. J. Mol. Biol. 360, 934-945 (2006).
15. Izumi, T. et al. Solubilization and partial purification of leukotriene C4 synthase from guinea-pig lung: A microsomal enzyme with high specificity towards 5,6-epoxide leukotriene A4. Biochim. Biophys. Acta 959, 305-315 (1988).
16. Yoshimoto, T., Soberman, R. J., Spur, B. & Austen, K. F. Properties of highly purified leukotriene C4 synthase of guinea pig lung. J. Clin. Invest. 81, 866-871 (1988).
17. Leslie, A. G. W. Recent changes to the MOSFLM package for processing film and image plate data. Joint CCP4 + ESF-EAMCB Newsl. Protein Crystallogr. 26, 27 (1992).
18. Collaborative. Computational Project, Number 4. The CCP4 suite: Programs for protein crystallography. Acta Crystallogr. D 50, 760-763 (1994).
19. Kabsch, W. Automaticprocessing of rotation diffraction data fromcrystals of initially unknown symmetry and cell constants. J. Appl. Crystallogr. 26, 795-800 (1993).
20. Uson, I. & Sheldrick, G. M. Advances in direct methods for protein crystallography. Curr. Opin. Struct. Biol. 9, 643-648 (1999).
21. de La Fortelle, E. & Bricogne, G. Maximum-likelihood heavy-atom parameter refinement for multiple isomorphous replacement and multiwavelength anomalous diffraction methods. Methods Enzymol. 276, 472-494 (1997).
22. Abrahams, J. P. & Leslie, A. G. W. Methods used in the structure determination of bovine mitochondrial F1 ATPase. Acta Crystallogr. D 52, 30-42 (1996).
23. Perrakis, A., Morris, R. & Lamzin, V. S. Automated proteinmodel building combined with iterative structure refinement. Nature Struct. Biol. 6, 458-463 (1999).
24. Emsley, P. & Cowtan, K. Coot: Model-building tools for molecular graphics. Acta Crystallogr. D 60, 2126-2132 (2004).
25. McCoy, A. J., Grosse-Kunstleve, R. W., Storoni, L. C. & Read, R. J. Likelihood-enhanced fast translation functions. Acta Crystallogr. D 61, 458-464 (2005).
26. Murshudov, G. N., Vagin, A. A. & Dodson, E. J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D 53, 240-255 (1997).
27. DeLano, W. L. The PyMOL Molecular Graphics System. (DeLano Scientific, Palo Alto, 2002).
28. Wallace, A. C., Laskowski, R. A. & Thornton, J. M. Ligplot - a program to generate schematic diagrams of protein ligand interactions. Protein Eng. 8, 127-134 (1995).